Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000935836-25-000082·ACUTA CAPITAL PARTNERS, LLC
Schedule 13D ownership disclosure
Whitehawk Therapeutics, Inc.
Common Stock · CUSIP: 00032Q104
Event date: 2024-12-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ACUTA CAPITAL PARTNERS, LLCReported CIK 0001582844
Shares: 1,849,402.00 · Class: 7.5%
- Anupam DalalReported CIK 0001602474
Shares: 1,921,297.00 · Class: 7.8%
- Acuta Capital Fund, LPReported CIK 0001601391
Shares: 1,572,698.00 · Class: 6.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000082
- Form type
- SCHEDULE 13D/A
- Filer
- ACUTA CAPITAL PARTNERS, LLC
- CIK
- CIK 1582844
- Filed
- Jan 24, 2025
- Reporting period
- Dec 19, 2024
- Description
- Schedule 13D beneficial ownership